Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joanna Wdzieczak-Bakala
Renal and Metabolic Clearance of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (AcSDKP) During Angiotensin-Converting Enzyme Inhibition in Humans
Hypertension
Internal Medicine
Related publications
N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: A Valuable Endogenous Anti-Fibrotic Peptide for Combating Kidney Fibrosis in Diabetes
Frontiers in Pharmacology
Pharmacology
Combination Treatment With N-Acetyl-Seryl-Aspartyl-Lysyl-Proline and Tissue Plasminogen Activator Provides Potent Neuroprotection in Rats After Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Scientific Letter: Ac-SDKP (N-Acetyl-Seryl-Aspartyl-Lysyl-Proline) and Galectin-3 Levels in Tuberculous Pericardial Effusion: Implications for Pathogenesis and Prevention of Pericardial Constriction
Heart
Cardiovascular Medicine
Cardiology
Converting Enzyme Inhibition and Renal Tissue Angiotensin II in the Rat
Hypertension
Internal Medicine
Cough and Angiotensin Converting Enzyme Inhibition
BMJ
Points: Cough and Angiotensin Converting Enzyme Inhibition
BMJ
Drug Points: Irreversible Renal Transplant Failure After Angiotensin Converting Enzyme Inhibition
BMJ
Inhibition of Angiotensin Converting Enzyme by Mushroom
Nippon Shokuhin Kagaku Kogaku Kaishi
Food Science
Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP
Hypertension
Internal Medicine
